학술논문

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions
Document Type
Review Article
Source
In The Lancet Oncology December 2020 21(12):e575-e588
Subject
Review and Opinion
Policy Review
Language
ISSN
1470-2045